Cordial Lifesciences Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Glimicord MV 2 Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glimicord MV 2 Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimicord MV 2 Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimicord MV 2 Tablet.
Glimicord MV 2 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimicord MV 2 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimicord MV 2 Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimicord MV 2 Tablet is a combination medication containing Glimepiride, Metformin, and Voglibose. It is used to treat Type 2 diabetes mellitus (DM). This medication helps improve blood glucose levels in adults when taken with dietary adjustments and regular exercise. Glimepiride lowers blood sugar by stimulating insulin release from the pancreas. Metformin reduces glucose production by the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, inhibits postprandial (after meal) glucose elevation. This combination is not suitable for treating Type 1 DM.
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. It's essential to consult with a healthcare professional for more information on possible side effects.
This medication should not be used if you have known allergies to its ingredients or excipients. It is also contraindicated for patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Glimicord MV 2 Tablet with alcohol is not recommended. It may further lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, using Glimicord MV 2 Tablet can lead to hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, a rapid heart rate, and feelings of anxiety or shakiness. These symptoms are more likely to occur if you miss meals, drink alcohol, exercise excessively, or take other antidiabetic medications simultaneously. Regular blood sugar monitoring is essential. Keep glucose tablets, honey, or fruit juice readily available.
Store this medication in its original packaging, tightly sealed. Refer to the instructions on the label or packaging for specific storage guidelines. Discard unused medication responsibly. Ensure it is inaccessible to pets, children, and other individuals.